Navigation Links
Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
Date:10/12/2010

I Market, France, Revenue Share Analysis by Therapeutic Category, %, 2009 62

Table 36: API Market, Italy, Revenues, $m, 2005–2015 64

Table 37: API Market, Italy, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 65

Table 38: API Market, Italy, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 66

Table 39: API Market, Italy, Revenue Share Analysis by Therapeutic Category, %, 2009 68

Table 40: API Market, Spain, Revenues, $m, 2005–2015 69

Table 41: API Market, Revenue Share Analysis by Product Type Based on Synthetic and Biotech Sector Spanish, %, 2009 and 2015 70

Table 42: API Market, Revenue Share Analysis by Product Type Based on Innovator and Generic sector APIs in the Spanish, %, 2009 and 2015 71

Table 43: API Market, Spain, Revenue Share Analysis by Therapeutic Category, %, 2009 72

Table 44: API Market, Asia-Pacific, Revenues, $m, 2005–2015 76

Table 45: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 77

Table 46: API Market, Asia-Pacific, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 78

Table 47: API Market, Asia-Pacific, Revenue Share Analysis by Country, %, 2009 and 2015 79

Table 48: API Market, Japan, Revenues, $m, 2005–2015 82

Table 49: API Market, Japan, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 83

Table 50: API Market, Japan, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 83

Table 51: API Market, Japan, Revenue Share Analysis by Therapeutic Applications, %, 2009 85

Table 52: API Market, China, Revenues, $m, 2005–2015 86

Table 53: API Market, China, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 87

Table 54: API Market, China, Revenue Sha
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
2. Reportlinker Adds European RIS/PACS Market
3. Reportlinker Adds U.S. Venous Access Catheter Market
4. Reportlinker Adds Pharmaceutical Contract Manufacturing: Industry and Market Prospects 2010-2025
5. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
6. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
7. Reportlinker Adds Global Vertebral Compression Fracture Devices Industry
8. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
9. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
10. Reportlinker Adds Antidiabetics Market Forecast
11. Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 Steven Rash , the CEO ... its operating subsidiary American Seed & Oil Company, presented ... investors yesterday in New York City.  Mr. Rash,s presentation ... American Seed & Oil Company has recently announced the ... Hemp Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has announced ... in 2014 - a Perspective of Mental Health Patient ... For the first time, in 2014, the ... the pharmaceutical industry held by patient groups with an ... organisations representing all therapy areas. - Findings ...
(Date:4/16/2015)... April 16, 2015 Mindray Medical International ... and marketer of medical devices worldwide, announced today ... Exchange Commission an Annual Report on Form 20-F that ... 31, 2014. An electronic version of Mindray,s Annual ... investor relations website at  http://ir.mindray.com  or  http://www.sec.gov . ...
Breaking Medicine Technology:American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... May 22 Shire plc (LSE: SHP, Nasdaq: ... results of a study showing that coadministration of the ADHD ... (PPI) Prilosec OTC(R) 40 mg (20 mg X 2), did ... concentration of d -amphetamine to be reached in the ...
... Calif., May 21 Telik, Inc. (Nasdaq: TELK ... study of canfosfamide (TELCYTA(R), TLK286) in combination with pegylated liposomal ... annual meeting of the American Society of Clinical Oncology (ASCO) ... in Orlando, FL.Details of the presentation are as follows:, ...
Cached Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8
(Date:4/17/2015)... CA (PRWEB) April 17, 2015 The American College ... event and Free Application Day on April 29. The event will ... Pioneer Square, located at 555 DeHaro St. in San Francisco, CA. ... a.m. – Check in at the DeHaro campus (room F), 11:10 ... Tour of campus, Noon – Light lunch with current students, faculty ...
(Date:4/17/2015)... Compare-autoinsurance.org has released a new blog post explaining how ... . , The online environment can help many ... should always compare multiple car insurance policies before deciding ... competitive one, which means that customers can find new ... now possible to compare online car insurance quotes on ...
(Date:4/17/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining the ... car insurance rates . , Falling asleep at ... have a big impact on auto insurance prices. The premiums ... claimed benefits. The newly released blog post talks more about ... , It is now possible to find low cost ...
(Date:4/17/2015)... Ticket Down is a reputable source of authentic Mumford ... life of last-minute show announcements is where fans of Mumford and ... early part of 2015, but beginning in June, the group responsible ... Cave,” and “Believe,” will perform a full-fledged tour across North America. ... at Coney Island in Brooklyn, NY and ends on August 22 ...
(Date:4/17/2015)... April 17, 2015 Verndale, a Global ... has once again been chosen as a Boston Business ... private company in the region. The BBJ’s Pacesetters represents ... from 2011 through 2014. This is the eighth consecutive ... years that Verndale has been honored with this award. ...
Breaking Medicine News(10 mins):Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:The Best Auto Insurance Quotes Are Available Online! 2Health News:Accidents Caused By Sleeping at The Wheel Can Increase Auto Insurance Costs 2Health News:Mumford and Sons Tickets in Clarkston/Detroit, Raleigh, Columbia/Baltimore, Chicago, Mansfield/Boston, Brooklyn, Calgary and Edmonton Now On Sale 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... , , , , , Quality Texas ... Award for Performance Excellence , ... Regional Medical Center at Grapevine is the 2009 recipient for the Texas Award for Performance ... Texas corporation that administers the Texas Award for Performance Excellence. , ...
... AMSTERDAM, June 17 , ... Among 100 Most,Influential Journals in Past Century , ... Publisher of the Last,100 Years in BioMedicine and the Life ... June 16th in Washington,DC. Twenty journals published by Elsevier, many ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... 5-year distribution agreement in the United States between its ... will supply blood tubing sets, including the ReadySet(R) and ... exclusively supply the bloodlines to certain customers for use ...
... Medco Health Solutions, and Blue Shield of California Look ... Calif., June 17 The State of California,s efforts ... received a shot in the arm today as The ... Blue Cross, Medco Health Solutions, Inc., and Blue Shield ...
... Collaboration will focus on the development of TMC207 and ... , SEATTLE, June 17 A new landmark ... (TB Alliance), a not-for-profit, product development partnership, and Tibotec ... today at the Pacific Health Summit in response to ...
... June 17 As job loss, bankruptcy, and divorce skyrocket ... hardships are struggling to cope. The burden of these concerns ... Joe Theu,s book "7 Proven Steps: How to Defeat Stress ... deal with the many different kinds of stress life can ...
Cached Medicine News:Health News:Tarrant County Hospital Takes Top Quality Award in Texas 2Health News:Tarrant County Hospital Takes Top Quality Award in Texas 3Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 2Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 3Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 4Health News:NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro 2Health News:NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro 3Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 2Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 3Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 4Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 5Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 6Health News:California Doctors to Get Wired in State's Largest e-Prescribing Initiative 7Health News:Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 2Health News:Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 3Health News:Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 4Health News:Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 5Health News:Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 6Health News:'7 Proven Steps: How to Defeat Stress Without Going Through the Embarrassment of Counseling': Proven Ways to Defeat Stress 2Health News:'7 Proven Steps: How to Defeat Stress Without Going Through the Embarrassment of Counseling': Proven Ways to Defeat Stress 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: